Corix Bioscience, Inc.

OTC: CXBS · Healthcare · Medical - Pharmaceuticals

PublicHQ Phoenix, AZ · MaricopaReports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 19

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ workforce scale, market scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

Market cap

$2.7k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Corix Bioscience, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Medivolve Inc.——Neurobiological Technologies, Inc.——Syros Pharmaceuticals, Inc.——Hydrogen Hybrid Technologies, Inc.——

Neighbors

Maricopa →

Southern Copper Corporation$13.4B89A Freeport-McMoRan Inc.$25.2B78B+Carvana Co.$20.3B70B Honeywell Aerospace Inc. Common Stock When Issued$17.4B——Republic Services, Inc.$16.6B81B+Axon Enterprise, Inc.$2.8B63C

Key facts

CEOChrist Froese

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersPhoenix, AZ

ExchangeOTC: CXBS

Employees2

IPO date2017-03-14

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.